A tighter archive for life-science signals.
Search once, then narrow by source or topic.
FDA puts clinical hold on Regenxbio gene therapies weeks before approval ruling
FDA puts clinical hold on Regenxbio gene therapies weeks before approval ruling
'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy
'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy
Boehringer channels midstage momentum into pivotal kidney disease trial
Boehringer channels midstage momentum into pivotal kidney disease trial
With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
Lisata reclaims China rights to solid tumor candidate ahead of acquisition
Lisata reclaims China rights to solid tumor candidate ahead of acquisition
After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance
Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance
Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial
Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial
European investment firm Gimv calls it quits on new life science financing
European investment firm Gimv calls it quits on new life science financing
New rules, higher stakes: Biopharma plays the long game in 2026
New rules, higher stakes: Biopharma plays the long game in 2026
Feds charge former Zynex execs in massive medtech billing fraud case
Feds charge former Zynex execs in massive medtech billing fraud case
Guardant Health gets FDA nod to expand use of blood test for colon cancer
Guardant Health gets FDA nod to expand use of blood test for colon cancer
AstraZeneca keeps UK research site on pause, but options open
AstraZeneca keeps UK research site on pause, but options open
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page